JPS61263917A - 脳機能正常化剤 - Google Patents

脳機能正常化剤

Info

Publication number
JPS61263917A
JPS61263917A JP10579885A JP10579885A JPS61263917A JP S61263917 A JPS61263917 A JP S61263917A JP 10579885 A JP10579885 A JP 10579885A JP 10579885 A JP10579885 A JP 10579885A JP S61263917 A JPS61263917 A JP S61263917A
Authority
JP
Japan
Prior art keywords
cerebral
agent
normalizing
pyrazolin
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP10579885A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0531523B2 (enrdf_load_stackoverflow
Inventor
Hiroyoshi Nishi
西　廣吉
Toshiaki Watanabe
俊明 渡辺
Toshiyuki Yuki
敏志 幸
Yasuhiro Morinaka
盛中　泰洋
Katsuhiko Izeki
克彦 伊関
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Yuka Pharmaceutical Co Ltd
Original Assignee
Mitsubishi Yuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Yuka Pharmaceutical Co Ltd filed Critical Mitsubishi Yuka Pharmaceutical Co Ltd
Priority to JP10579885A priority Critical patent/JPS61263917A/ja
Priority to DK227186A priority patent/DK169672B1/da
Priority to DE8686106817T priority patent/DE3673273T2/de
Priority to EP86106817A priority patent/EP0208874B1/en
Publication of JPS61263917A publication Critical patent/JPS61263917A/ja
Priority to US07/122,516 priority patent/US4857542A/en
Publication of JPH0531523B2 publication Critical patent/JPH0531523B2/ja
Priority to US08/309,558 priority patent/USRE35801E/en
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP10579885A 1985-05-20 1985-05-20 脳機能正常化剤 Granted JPS61263917A (ja)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP10579885A JPS61263917A (ja) 1985-05-20 1985-05-20 脳機能正常化剤
DK227186A DK169672B1 (da) 1985-05-20 1986-05-16 Farmaceutiske præparater indeholdende pyrazolonderivater som aktiv bestanddel og anvendelsen af pyrazolonderivater til fremstilling af farmaceutiske præparater
DE8686106817T DE3673273T2 (de) 1985-05-20 1986-05-20 Prophylaktische und therapeutische mittel fuer kreislaufkrankheiten.
EP86106817A EP0208874B1 (en) 1985-05-20 1986-05-20 Prophylactic and therapeutic agent for circulatory disorders
US07/122,516 US4857542A (en) 1985-05-20 1987-11-19 Prophylactic and therapeutic composition for circulatory disorders and method of treatment
US08/309,558 USRE35801E (en) 1985-05-20 1994-09-20 Prophylactic and therapeutic composition for circulatory disorders and method of treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10579885A JPS61263917A (ja) 1985-05-20 1985-05-20 脳機能正常化剤

Publications (2)

Publication Number Publication Date
JPS61263917A true JPS61263917A (ja) 1986-11-21
JPH0531523B2 JPH0531523B2 (enrdf_load_stackoverflow) 1993-05-12

Family

ID=14417138

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10579885A Granted JPS61263917A (ja) 1985-05-20 1985-05-20 脳機能正常化剤

Country Status (1)

Country Link
JP (1) JPS61263917A (enrdf_load_stackoverflow)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01242526A (ja) * 1988-03-23 1989-09-27 Takeda Chem Ind Ltd カルバメート化合物
JPWO2005054205A1 (ja) * 2003-12-05 2007-06-28 学校法人東海大学 蛋白修飾物生成抑制剤
US8076368B2 (en) 2003-11-12 2011-12-13 Lead Chemical Co., Ltd, Percutaneous absorption type cerebral protective agent

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2414586C (en) 2000-06-29 2009-09-29 Mitsubishi Pharma Corporation Agent for therapeutic treatment of optic nerve diseases and the like
JP2004346067A (ja) * 2003-04-28 2004-12-09 Mitsubishi Pharma Corp 抗血栓薬の治療可能時間を延長するための薬剤
ES2707781T3 (es) 2004-08-10 2019-04-05 Mitsubishi Tanabe Pharma Corp Compuestos de pirazolona para el tratamiento de trastornos cerebrovasculares
JPWO2006126625A1 (ja) * 2005-05-25 2008-12-25 田辺三菱製薬株式会社 ピラゾロン誘導体を含む医薬
JP2008001605A (ja) * 2006-06-20 2008-01-10 Mitsubishi Pharma Corp ピラゾロン化合物を含有する水溶液剤
EP2311430A1 (en) 2007-11-22 2011-04-20 Mitsubishi Tanabe Pharma Corporation A plastic container comprising cyclic polyolefin layer
KR20140024068A (ko) * 2008-11-20 2014-02-27 테이코쿠 팔마 유에스에이, 인코포레이티드 피라졸론 유도체 제제
WO2010087306A1 (ja) 2009-01-29 2010-08-05 株式会社林原生物化学研究所 抗神経変性疾患剤
EP3520788A1 (en) 2011-09-05 2019-08-07 Mitsubishi Tanabe Pharma Corporation Medicinal agent for treating amyotrophic lateral sclerosis or preventing progression of phase of amyotrophic lateral sclerosis
JP6298206B1 (ja) 2017-08-08 2018-03-20 田中　正彦 ピラゾロン誘導体を含む医薬
KR102665924B1 (ko) 2018-02-15 2024-05-14 후지모리 고교 가부시키가이샤 플라스틱 용기
WO2019167178A1 (ja) 2018-02-28 2019-09-06 田辺三菱製薬株式会社 ３－メチル－１－フェニル－２－ピラゾリン－５－オン原薬の分析方法、筋萎縮性側索硬化症の治療および筋萎縮性側索硬化症の進行抑制、ならびに、３－メチル－１－フェニル－２－ピラゾリン－５－オン原薬を含む薬剤の製造方法
US11826352B2 (en) 2018-11-02 2023-11-28 Mitsubishi Tanabe Pharma Corporation Edaravone suspension for oral administration
PL3875085T3 (pl) 2018-11-02 2024-10-21 Mitsubishi Tanabe Pharma Corporation Zawiesina edarawonu do podania doustnego
CN116761601A (zh) 2020-11-12 2023-09-15 田边三菱制药株式会社 依达拉奉口服给药用医药组合物及其给药方法
TW202228678A (zh) 2020-11-12 2022-08-01 日商田邊三菱製藥股份有限公司 依達拉奉經口投予用醫藥組成物及其投予方法
US12194025B2 (en) 2020-11-12 2025-01-14 Mitsubishi Tanabe Pharma Corporation Pharmaceutical composition for oral administration of edaravone and method of administering same
CN119790165A (zh) * 2022-07-01 2025-04-08 田边三菱制药株式会社 用于评估依达拉奉响应性的组合物和方法

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01242526A (ja) * 1988-03-23 1989-09-27 Takeda Chem Ind Ltd カルバメート化合物
US8076368B2 (en) 2003-11-12 2011-12-13 Lead Chemical Co., Ltd, Percutaneous absorption type cerebral protective agent
JPWO2005054205A1 (ja) * 2003-12-05 2007-06-28 学校法人東海大学 蛋白修飾物生成抑制剤
JP4837992B2 (ja) * 2003-12-05 2011-12-14 学校法人東海大学 蛋白修飾物生成抑制剤

Also Published As

Publication number Publication date
JPH0531523B2 (enrdf_load_stackoverflow) 1993-05-12

Similar Documents

Publication Publication Date Title
JPS61263917A (ja) 脳機能正常化剤
DE69724108T2 (de) Isochinolinderivate und arzneimittel
US4826860A (en) Substituted 2-aminobenzothiazoles and derivatives useful as cerebrovascular agents
CA3091012A1 (en) A method of treating pain
PT99690B (pt) Metodo para o tratamento de doencas utilizando derivados de 2'-o-alquil-adenosina e para a preparacao de composicoes que os contem e de um hidrato de 6-ciclo- -hexil-2'-ometil-adenosina
LT3317B (en) Neuromuscular blocking agents
HU202106B (en) Process for producing pharmaceutical compositions containing pyrazolin derivatives
ES2210399T3 (es) Farmacos para profilaxis/tratamiento de las complicaciones de la diabetes.
JPH04264030A (ja) 抗喘息剤
JPH03215426A (ja) 血糖上昇抑制剤
US4918090A (en) Substituted 2-aminbenzothiazoles and derivatives useful as cerebrovascular agents
WO1994005290A1 (en) Platelet aggregation inhibitor
KR20020063254A (ko) 신경계 장해의 치료 및/또는 예방약
US4128555A (en) 3-Phenoxypyridine monosulfate and a method for its production
US6071968A (en) Phenylenediamine derivative radical scavenger, brain-infarction depressant, and brain-edema depressant
US4971983A (en) Substituted 2-aminobenzothiazoles and derivatives useful as cerebrovascular agents
TW322473B (enrdf_load_stackoverflow)
CN101648951A (zh) 一种己酮可可碱衍生物
WO1994009784A1 (en) Platelet aggregation inhibitor
EP0223811A1 (en) Use of nicorandil or pinacidil for the treatment of peripheral vascular disease
JP2003267871A (ja) 放射線障害予防剤
JPS63130592A (ja) 過酸化脂質生成抑制剤
JPS59231057A (ja) カルボン酸アミド化合物およびその誘導体
US4024259A (en) 3-Anilino-2,4-diazabicyclo[3.2.1]octenes
JP3247763B2 (ja) キサンチン誘導体からなる血液循環の中断による神経損傷の治療用医薬

Legal Events

Date Code Title Description
S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110512

Year of fee payment: 18

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110512

Year of fee payment: 18

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110512

Year of fee payment: 18